Cargando…

Does the use of a cytokine 'filter' during cardiopulmonary bypass make sense?

Detalles Bibliográficos
Autores principales:	Clermont, G, Kellum, J, Bartels, J, Chang, S, Chow, C, Vodovotz, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099736/ http://dx.doi.org/10.1186/cc2616

Ejemplares similares

Predicting the response to therapy from a mathematical model
por: Clermont, G, et al.
Publicado: (2004)

Does cardiopulmonary bypass affect the procalcitonin level?
por: Kalay, F, et al.
Publicado: (2005)

Does cardiopulmonary bypass increase the risk of postoperative acute kidney injury after coronary artery bypass grafting?
por: Karmali, A, et al.
Publicado: (2015)

Fibrinolysis during cardiopulmonary bypass detected with thromboelastography
por: Hájek, R, et al.
Publicado: (2007)

Complement activation and excessive bleeding in cardiopulmonary bypass surgery
por: Iribarren, J, et al.
Publicado: (2007)

Factors associated with excessive bleeding in cardiopulmonary bypass patients
por: Jimenez Rivera, J, et al.
Publicado: (2006)

Influence of amiodarone treatment on inflammation during cardiopulmonary bypass
por: Delle Karth, G, et al.
Publicado: (2005)

Impact of body mass index on postoperative bleeding in cardiopulmonary bypass
por: Brouard, M, et al.
Publicado: (2007)

Mathematical modeling of community-acquired pneumonia patients
por: Sarkar, J, et al.
Publicado: (2009)

Macrophage chemoattractant protein 1 and outcome in cardiopulmonary bypass
por: Pereira, KC, et al.
Publicado: (2005)

Ketamine and the coagulation response during and after cardiopulmonary bypass
por: Husedzinovic, I, et al.
Publicado: (2005)

Sublingual microcirculation is impaired during cardiopulmonary bypass in cardiac surgery
por: den Uil, C, et al.
Publicado: (2007)

Predictive genetic factors for bleeding in cardiac surgery patients with cardiopulmonary bypass
por: Iribarren Sarrias, J, et al.
Publicado: (2006)

Use of procalcitonin for identification of postoperative complications after coronary artery bypass surgery with cardiopulmonary bypass
por: Baysal, A, et al.
Publicado: (2014)

Microvascular effects of pulsatile versus nonpulsatile perfusion during cardiopulmonary bypass
por: Elbers, PW, et al.
Publicado: (2010)

Hematocrit of 20% versus 25% during normothermic cardiopulmonary bypass for elective coronary artery bypass graft surgery
por: von Heymann, C, et al.
Publicado: (2005)

Oral neutrophil quantitation in patients undergoing elective cardiopulmonary bypass
por: Wilcox, ME, et al.
Publicado: (2012)

Role of plasminogen activator inhibitor-1 polymorphism on the development of vasoplegic syndrome associated with cardiopulmonary bypass
por: Jimenez, J, et al.
Publicado: (2007)

Continuous pulse contour analysis after cardiopulmonary bypass in cardiac surgery
por: Sander, M, et al.
Publicado: (2005)

Etomidate and relative adrenal insufficiency in cardiopulmonary bypass surgery: impact on the postoperative hemodynamic status
por: Lorenzo, L, et al.
Publicado: (2008)

Relative adrenal insufficiency in cardiopulmonary bypass surgery patients: impact on the postoperative hemodynamic status
por: Jimenez, J, et al.
Publicado: (2009)

Safety and effectiveness of different treatment regimes with tranexamic acid in elective cardiopulmonary bypass patients
por: Iribarren, JL, et al.
Publicado: (2011)

Is procalcitonin a valuable marker for identification of postoperative complications after coronary artery bypass graft surgery with cardiopulmonary bypass?
por: Baysal, A, et al.
Publicado: (2015)

Strong ion acid–base abnormality and lactate:pyruvate ratio in children following cardiopulmonary bypass
por: Hatherill, M, et al.
Publicado: (2005)

Cardiopulmonary bypass and recombinant plasminogen activator for treatment of experimental fatal pulmonary embolism
por: Kjærgaard, B, et al.
Publicado: (2007)

Do erythrocytes subjected to cardiopulmonary bypass exhibit changes in their membrane mechanical properties?
por: Clark, T, et al.
Publicado: (2013)

Endothelial protein C receptor expression after cardiopulmonary bypass in adult cardiac surgical patients
por: Hajek, R, et al.
Publicado: (2010)

Tissue oxygen saturation during anaesthesia, cardiopulmonary bypass and intensive care stay for cardiac surgery
por: Sanders, J, et al.
Publicado: (2008)

Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery
por: Klein, DJ, et al.
Publicado: (2011)

Effects of cardiopulmonary bypass on the accuracy of non-invasive hemoglobin measurement by pulse co-oximetry
por: Tokuda, K, et al.
Publicado: (2015)

Impact of antiplatelet therapy and cardiopulmonary bypass on platelet function in patients undergoing coronary artery bypass grafting using multiple electrode aggregometry
por: Gersak, B, et al.
Publicado: (2013)

Clinical outcome and mortality associated with postoperative low cardiac output after cardiopulmonary bypass: a cohort study
por: Jimenez, J, et al.
Publicado: (2008)

Tranexamic acid effects on postoperative bleeding in cardiopulmonary bypass surgery according to the plasminogen activator inhibitor-1 polymorphism
por: Brouard, M, et al.
Publicado: (2008)

Effectiveness of an underbody forced warm-air blanket in preventing postoperative hypothermia after coronary artery bypass graft surgery with normothermic cardiopulmonary bypass
por: Teodorczyk, JE, et al.
Publicado: (2009)

Infusion of sodium sulfide improves myocardial and endothelial function in a canine model of cardiopulmonary bypass
por: Szabó, C, et al.
Publicado: (2007)

Preoperative tissue Doppler imaging and diastolic filling patterns on postoperative new-onset atrial fibrillation in cardiopulmonary bypass surgery
por: Iribarren, J, et al.
Publicado: (2008)

Vasoplegic syndrome after cardiopulmonary bypass surgery – associated factors and clinical outcomes: a nested case-control study
por: Iribarren, J, et al.
Publicado: (2007)

Perioperative changes in plasma brain natriuretic peptide and N-terminal probrain natriuretic peptide in patients undergoing coronary bypass surgery under cardiopulmonary bypass
por: Ciufu, M, et al.
Publicado: (2004)

Use, type and duration of cardiopulmonary bypass are related to acute kidney injury occurrence and urinary NGAL concentrations
por: García Rodríguez San Miguel, T
Publicado: (2013)

Effects of levosimendan started 24 hours before cardiopulmonary bypass in patients admitted to the ICU with an ejection fraction lower than 30%
por: Duchateau, J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_p8o8uja5dpf8se7leiujgs91jq